Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
05.24.24
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
05.16.24
OpGen Announced 1-for-10 Reverse Stock Split
04.29.24
OpGen Provides Update on Business Operations and Strategic Opportunities

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events